$RCEL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AVITA Medical, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AVITA Medical, Inc.. Get notifications about new insider transactions in AVITA Medical, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 11 2021 | RCEL | AVITA Medical, Inc ... | Holder Michael | Chief Financial Off ... | Option Exercise | A | 19.91 | 112,500 | 2,239,875 | 112,500 | |
| Mar 25 2021 | RCEL | AVITA Medical, Inc ... | Holder Michael | Chief Financial Off ... | Option Exercise | A | 22.25 | 37,500 | 834,375 | 37,500 | |
| Mar 19 2021 | RCEL | AVITA Medical, Inc ... | Ekins Sean | Sr. VP of Finance | Option Exercise | A | 21.93 | 30,000 | 657,900 | 30,000 | |
| Dec 16 2020 | RCEL | AVITA Medical, Inc ... | Ekins Sean | Sr. VP of Finance | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| Sep 16 2020 | RCEL | Avita Therapeutics ... | PERRY MICHAEL S | Chief Executive Off ... | Sell | S | 27.41 | 9,000 | 246,690 | 425,087 | 434.1 K to 425.1 K (-2.07 %) |
| Sep 16 2020 | RCEL | Avita Therapeutics ... | PERRY MICHAEL S | Chief Executive Off ... | Sell | S | 27.23 | 23,769 | 647,230 | 434,087 | 457.9 K to 434.1 K (-5.19 %) |
| Sep 16 2020 | RCEL | Avita Therapeutics ... | PERRY MICHAEL S | Chief Executive Off ... | Sell | S | 26.99 | 15,092 | 407,333 | 457,856 | 472.9 K to 457.9 K (-3.19 %) |
| Sep 16 2020 | RCEL | Avita Therapeutics ... | PERRY MICHAEL S | Chief Executive Off ... | Grant | A | 0.00 | 68,504 | 0 | 472,948 | 404.4 K to 472.9 K (+16.94 %) |
| Sep 11 2020 | RCEL | Avita Therapeutics ... | Shiroma Donna | General Counsel | Option Exercise | A | 4.38 | 4,400 | 19,272 | 8,600 | |
| Sep 11 2020 | RCEL | Avita Therapeutics ... | PERRY MICHAEL S | Chief Executive Off ... | Option Exercise | A | 5.99 | 25,000 | 149,750 | 150,000 | |
| Sep 11 2020 | RCEL | Avita Therapeutics ... | PERRY MICHAEL S | Chief Executive Off ... | Sell | S | 26.02 | 20,000 | 520,400 | 404,444 | 424.4 K to 404.4 K (-4.71 %) |
| Sep 11 2020 | RCEL | Avita Therapeutics ... | PERRY MICHAEL S | Chief Executive Off ... | Sell | S | 26.26 | 7,128 | 187,181 | 424,444 | 431.6 K to 424.4 K (-1.65 %) |
| Sep 11 2020 | RCEL | Avita Therapeutics ... | PERRY MICHAEL S | Chief Executive Off ... | Grant | A | 0.00 | 83,333 | 0 | 431,572 | 348.2 K to 431.6 K (+23.93 %) |
| Sep 11 2020 | RCEL | Avita Therapeutics ... | Liberto Erin | Chief Commercial Of ... | Option Exercise | A | 5.03 | 6,000 | 30,180 | 24,000 | |
| Sep 11 2020 | RCEL | Avita Therapeutics ... | Quick Andrew | Chief Technology Of ... | Option Exercise | A | 6.32 | 4,038 | 25,520 | 16,150 | |
| Sep 11 2020 | RCEL | Avita Therapeutics ... | Liberto Erin | Chief Commercial Of ... | Option Exercise | A | 5.03 | 6,000 | 30,180 | 24,000 | |
| Sep 11 2020 | RCEL | Avita Therapeutics ... | Quick Andrew | Chief Technology Of ... | Option Exercise | A | 6.32 | 4,038 | 25,520 | 16,150 | |
| Jul 21 2020 | RCEL | Avita Therapeutics ... | McIntyre David | Chief Financial Off ... | Buy | P | 22.70 | 393 | 8,921 | 893 | 500 to 893 (+78.60 %) |
| Jul 21 2020 | RCEL | Avita Therapeutics ... | McIntyre David | Chief Financial Off ... | Buy | P | 23.85 | 300 | 7,155 | 500 | 200 to 500 (+150.00 %) |
Page: 1